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Abstract
Post-transcriptional events regulate herpesvirus gene expression, yet few herpesvirus RNA-
binding proteins have been identified. We used an unbiased approach coupling oligo(dT) affinity 
capture with proteomics to identify viral RNA-associated proteins during infection. Using this 
approach, we identified and confirmed changes in the abundance or activity of two host RNA-
associated proteins, DHX9 and DDX3, in cells infected with human cytomegalovirus (HCMV). 
We also identified and confirmed previously unreported activities for the HCMV US22 and pp71 
proteins as RNA-associated viral proteins and confirmed that a known viral RNA-binding protein, 
pTRS1, associates with RNA in infected cells. Further, we found that HCMV pp71 co-sedimented 
with polysomes, associated with host and viral RNAs, and stimulated the overall rate of protein 
synthesis. These results demonstrate that oligo(dT) affinity capture coupled with proteomics 
provides a rapid and straightforward means to identify RNA-associated viral proteins during 
infection that may participate in the post-transcriptional control of gene expression.
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Introduction
Human cytomegalovirus (HCMV) is a ubiquitous human pathogen that infects the majority 
of the population (12). Healthy individuals carry HCMV asymptomatically for the rest of 
their lives. However, immune-compromised individuals are at risk for severe life threatening 
disease caused by reactivated HCMV infections (74). In addition, HCMV can be 
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congenitally passed from mother to child during pregnancy and HCMV is a leading cause of 
infectious birth defects (49).
Regulation of HCMV gene expression is complex and occurs at both the transcriptional and 
post-transcriptional levels. Like host mRNAs, viral precursor RNAs are transcribed and 
mature in the nucleus, and then transported to the cytosol where they are translated into 
protein. Ribonucleoprotein (RNP) complexes play a critical role in each step of host mRNA 
maturation and quality control (1, 22) and therefore play important roles in the post-
transcriptional control of gene expression. Herpesvirus transcripts are also subject to post-
transcriptional regulation. However, unlike host transcripts, many herpesvirus transcripts are 
unspliced and therefore require a distinct complement of RNPs for their maturation and 
export (85). For example human herpesviruses encode homologs of the HCMV UL69 
protein (pUL69), which interacts with the host RNA export machinery and facilitates the 
transport of unspliced viral mRNAs into the cytoplasm (62, 63). In addition herpesvirus 
proteins manipulate host post-transcriptional regulatory systems in order to modify the 
expression of antiviral host messages and miRNAs (10, 54, 61, 86). For HCMV, post-
transcriptional regulation plays an essential role in the kinetics of viral gene expression. 
mRNAs for several late genes are transcribed early in infection; however, late mRNAs are 
not translated into protein until viral DNA replication occurs (26, 92). Whether HCMV 
encodes additional proteins that impact post-transcriptional control of viral gene expression 
remains unknown.
One approach to identify proteins involved in post-transcriptional regulation of gene 
expression involves the identification of RNA-associated proteins. For example, RNA-
affinity chromatography coupled with mass spectrometry has been used to identify RNA 
binding proteins in mammalian cells (4, 14). Similar strategies have been used to define host 
and viral proteins that associate with specific viral RNAs (56, 60, 76). Such approaches have 
proven useful in defining the complement of RNA binding proteins that might participate in 
RNA metabolism, trafficking, or translation.
In order to identify HCMV proteins that might function in post-transcriptional regulation, 
we used an unbiased proteomics approach based on oligo(dT) affinity purification to 
identify mRNA-associated proteins during HCMV infection. We find that infection alters 
the abundance and activity of two host RNA-binding proteins, DHX9 and DDX3X. In 
addition, we identified and confirmed previously undescribed mRNA-binding activities for 
the HCMV US22 protein and the viral tegument protein pp71. Further studies revealed that 
pp71 bound mRNA throughout a time course of infection and associated with polysomes in 
HCMV infected cells. Both host and viral mRNAs co-purified with pp71 from infected cell 
lysates and pp71 associated with mRNA in the absence of additional viral proteins. Together 
these results demonstrate the utility of oligo(dT) affinity capture coupled with proteomics to 
identify new RNA-binding activities for herpesvirus proteins.
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Human foreskin fibroblasts (HFFs) were maintained in Dulbecco’s Modified Eagle Medium 
(DMEM) with 10% Newborn Calf Serum (NCS) at 37°C with 5% CO2 and used between 
passages 7 and 14. HEK 293T and HeLa cells were maintained in DMEM with 10% Fetal 
Bovine Serum (FBS). Mutant HCMV AD169 strains expressing pTRS1 (BADinTRS1GFP) 
and pUS22 (BADinUS22GFP) with C-terminal GFP fusion tags under the control of their 
native promoters were made by lambda/red-mediated recombineering (107) (87) using the 
BADwt BAC as the parental strain. HCMV BADinGFP (ADGFP), BADinTRS1GFP and 
BADinUS22GFP viruses were grown on HFFs. Unless otherwise noted, HFFs were infected 
at an MOI of three for one hour at 37°C and 5% CO2 in DMEM plus 10% NCS.
Cloning and transfections
The pp71-HA plasmid was constructed by amplifying the UL82 open reading frame from 
the BADinGFP BAC using gene specific primers that include restriction sites for BamHI 
and EcoRI as well as a HA tag sequence for the C terminus of the protein. The amplicon was 
ligated into the pcDNA3.1 multi-cloning site in between the BamHI and EcoRI sites. The 
pUL35A-GFP mammalian expression vector was produced by amplifying the UL35A open 
reading frame from the BADinGFP BAC using gene specific primers (Forward: 
GGAGATAGAACCATGATGATCGAGGGCGCCTCTCGGCAGACG, Reverse: 
CAAGAAAGCTGGGTCGAGATGCCGTAGGTTTTCGGCCAGATCG) The amplicon 
was recombined into pDEST47 using Gateway Cloning (Life Technologies).
Oligo(dT) capture and mass spectrometry
Confluent HFFs were mock infected or infected with ADGFP at an MOI of three. At 72 hpi 
the cells were washed with PBS and harvested by scraping. The cells were pelleted by 
centrifugation at 2200 rpm for 10 minutes and resuspended in 1 mL oligo(dT) buffer (40 
mM HEPES pH 7.6, 500 mM NaCl, 1 mM EDTA, 0.3% CHAPS, Complete EDTA-free 
protease inhibitor (Roche)) and incubated on ice for 10 minutes. Insoluble material was 
removed by centrifugation at 4°C and 15,000 rpm. Where indicated, the supernatant was 
treated with micrococcal nuclease for 30 minutes at room temperature with rocking. The 
supernatant was mixed with 10 mg of Oligo(dT)-Cellulose Type 7 (GE Health Sciences) 
beads that were rehydrated in 100 µL oligo(dT) buffer plus 20 mg/mL yeast tRNA prior to 
mixing. The slurry was nutated for one hour at 4°C. The beads were pelleted and washed 
three times with oligo(dT) buffer and twice with wash buffer (250 mM NaCl, 40 mM 
HEPES pH 7.6, 1 mM EDTA, Complete Protease inhibitors, 20 mg/mL yeast tRNA). The 
mRNA and bound proteins were eluted in 100 µL elution buffer (40 mM HEPES pH 7.6, 1 
mM EDTA, Complete Protease inhibitors, 40 mg/mL soluble oligo(dT) with mixing for one 
hour at 4°C. Protein levels were estimated by resolving a 10 µL aliquot of the eluate on a 
10% SDS-PAGE gel and staining with GelCode Blue (Pierce). The proteins were digested 
with trypsin in solution and purified over C-18 columns. The resulting peptides were 
identified using liquid chromatography coupled tandem mass spectrometry (LC-MS/MS). 
MS spectra were searched using the MASCOT algorithm against the current version of the 
Human IPI database.
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Oligo(dT) capture of RNA binding proteins and western blots
Infected HFFs or transfected HEK 293T or HeLa cells were harvested by scraping and 
pelleted by centrifugation at 1500 rpm. Cells were lysed in 1 mL oligo(dT) buffer and 
incubated on ice for 10 minutes. Insoluble material was removed by centrifugation at 4°C 
and 15,000 rpm. Where indicated the supernatant was treated with micrococcal nuclease for 
30 minutes at room temperature with rocking. The supernatant was then mixed with Oligo 
(dT)-Cellulose Type 7 (GE Health Sciences) beads and nutated for one hour at 4°C. The 
beads were washed three times in oligo(dT) buffer and resuspended in denaturing protein 
sample buffer (0.1 M Tris-HCl pH 6.8, 6% Glycerol, 2% SDS, 0.1 M DTT, 0.002% 
Bromophenol Blue). Proteins were separated by 10% SDS-PAGE gels and transferred to 
Protran nitrocellulose membrane (Whatmann). Blots were probed with primary antibodies 
specific for PABP (1:2000; Cell Signaling), GFP (1:1000; Roche cat# 11814460001) or 
pp71 (45) followed by HRP-conjugated secondary antibodies (KPL) followed by ECL 
(Advansta) and visualization on x-ray film or using a digital chemiluminesence detection 
system (Bio-Rad).
Immunoprecipitations
Transfected HEK 293T or HeLa cells were lysed in 1 mL RIPA buffer (50 mM Tris-HCl pH 
7.4, 1% NP-40, 0.25% sodium deoxycholate, 150 mM NaCl, 1mM EDTA) containing 
protease inhibitors (Complete EDTA-free protease inhibitor; Roche) followed by incubation 
on ice for 10 minutes. Insoluble material was removed by centrifugation at 4°C and 15,000 
rpm. The supernatants were then treated with or without micrococcal nuclease for 30 
minutes at room temperature with rocking. Supernatants were pre-cleared by nutating with 
Protein A/G beads (Santa Cruz Biotechnology) at 4°C for 30 minutes. The pre-clear beads 
were then pelleted and discarded. The pre-cleared lysates were then incubated with 2 µg 
GFP antibody (Roche) at 4°C with nutating for one hour. Immune complexes were captured 
on Protein A/G sepharose beads by nutating at 4°C for one hour. The beads were pelleted 
and washed three times in RIPA buffer and resuspended in denaturing protein sample buffer. 
Immune complexes were resolved on 10% SDS-PAGE gels and analyzed by Western blot.
Identification of mRNAs associated with pp71 immune complexes
Infected HFFs were lysed and pre-cleared for immunoprecipitation as above. A portion of 
the lysate was removed for the isolation of total RNA. The pre-cleared lysates were then 
incubated with 100 µL Protein A/G beads that had been pre-conjugated to pp71 or IE1 
antibodies. The immune complexes were formed at 4°C with nutating for one hour. The 
beads were then pelleted and washed three times in RIPA buffer before being resuspended 
in 100 µL RIPA buffer. 10 µL aliquots of resuspended beads were removed, mixed with 
protein sample buffer (0.5 M Tris-HCl pH 6.8, 30% Glycerol, 10% SDS, 0.6 M DTT, 
0.012% bromophenol blue) and probed by western blot for pp71 and Tubulin (Sigma). RNA 
was extracted from the remaining beads with 1 mL Trizol and RNA. cDNA was prepared 
from the captured RNAs and total RNA using random hexamer primers and the High 
Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Quantitative RT-PCR 
(qRT-PCR) was performed using a Lightcycler 480 with SYBR Green Master Mix (Roche) 
and primers for IE1 (Forward: CAAGTGACCGAGGATTGCAA, Reverse: 
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CACCATGTCCACTCGAACCTT), UL44 (Forward: 
GCGTGCAAGTCTCGACTAAGGAGC, Reverse: 
AAGTACTGTGCCTCTTAGTCGGGGG), pp28 (Forward: 
GTGTCCCATTCCCGACTCG, Reverse: TTCACAACGTCCACCCACC) and GAPDH 
(Forward: CTGTTGCTGTAGCCAAATTCGT, Reverse: 
ACCCACTCCTCCACCTTTGAC). In order to normalize detected mRNA levels for each 
gene, threshold cycles (CT) from immunoprecipitated samples were normalized back to the 
CT obtained from total RNA. The normalized CT for each gene was then compared between 
the two conditions: the nonspecific IE1 control IP and the pp71 IP. The Fold increase for 
each gene was calculated from the difference in normalized CT between these two 
conditions.
Confocal Microscopy
HFFs were plated on glass cover slips and infected at a multiplicity of one with the indicated 
virus strain. At the indicated times post infection cells were washed and fixed using 2% 
paraformaldehyde, blocked in 1% BSA for at least one hour at 4°C and then probed with 
pp71 antibodies and fluorescent anti-mouse secondary antibodies. Coverslips were mounted 
onto slides with Vectashield mounting solution (Vector Laboratories). Cells were imaged 
using a Zeiss CLSM 710 Spectral Confocal Laser Scanning Microscope.
Metabolic labeling of nascent proteins
HeLa cells plated in 6-well dishes were transfected with the indicated expression plasmids 
and harvested 24 hours after transfection. Where indicated samples were treated with Torin1 
(96) (250 nM) or cycloheximide (100 µg/mL) for 16 hours prior to harvest. Forty-five 
minutes prior to harvest cell growth media was replaced with media lacking methionine and 
cysteine. After fifteen minutes 125 µCi of 35S-methionine/cysteine was added (Perkin 
Elmer) to the culture media. Cells were labeled for 30 minutes at 37°C and then washed 
twice with ice-cold PBS prior to harvest by scraping. Cell pellets were lysed in RIPA buffer, 
insoluble material was removed by centrifugation at 4°C and 15,000 rpm, and equal portions 
of lysate were precipitated in a solution containing 0.1 mg/mL BSA and 20% TCA. The 
proteins were precipitated on ice for thirty minutes and the precipitated proteins were bound 
to glass fiber filters (Whatmann) using a vacuum manifold. The filters were washed twice 
with 20% TCA followed by two washes with 100% ethanol and allowed to air dry for 
twenty minutes. Radioactive proteins retained on the filters were quantified in a scintillation 
counter. Protein concentrations were determined by Bradford assay. To visualize changes in 
nascent protein synthesis, 10 µg of each sample were separated on 10% SDS-PAGE gels, 
which were subsequently dried and visualized by autoradiography.
Results
Unbiased proteomic profiling of RNA-associated proteins in HCMV-infected cells
In order to identify proteins associated with mRNA during infection, we performed an 
unbiased screen for proteins that co-purify with oligo(dT) cellulose from HCMV infected 
cells. Figure 1 shows the basic details of the assay. Human foreskin fibroblasts (HFFs) were 
infected with HCMV for 72 hours and then lysed in a buffer containing high salt (500 mM 
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NaCl) in order to limit non-specific protein:protein interactions. mRNA:protein complexes 
were isolated by incubating the lysates with oligo(dT) conjugated cellulose beads. As high 
salt concentrations lower the base pairing stringency of RNA:DNA interactions (95), we 
decreased the salt concentration during the wash and elution steps to limit non-specific RNA 
binding to the oligo(dT) DNA oligomers. A substantial source of false positives in 
proteomics experiments arises from nonspecific binding of proteins to the affinity matrix 
(82). Therefore the mRNA:protein complexes were eluted from the beads by the addition of 
excess soluble oligo(dT), leaving non-specific interactors bound to the matrix. The eluted 
lysates were separated on SDS-PAGE gels and visualized by Coomassie staining (Fig 1B). 
Numerous bands were enriched in abundance in the oligo (dT) eluates as compared to whole 
cell lysates. The eluates from HCMV infected cells appeared to contain all of the bands 
found in uninfected eluates, along with several unique bands (Fig 1B). We performed the 
assay in the presence of micrococcal nuclease in order to visualize levels of nonspecific 
proteins bound to the beads in the absence of RNA (Fig 1B). While some non-specific 
interactors remained, micrococcal nuclease treatment reduced the number and intensity of 
bands, suggesting that many of the captured proteins were retained in an RNA-dependent 
manner.
The complement of proteins in the oligo(dT) eluate was determined using liquid 
chromatography coupled with tandem mass spectrometry (LC-MS/MS). Initial inspection of 
the eluted proteins revealed that both the infected and uninfected samples contained many 
known RNA-binding proteins (Table 1, Table S1). Gene ontogeny analysis revealed that the 
set of proteins enriched in the oligo(dT) eluate were significantly associated with RNA-
binding, post-transcriptional regulation, and splicing (Fig. 1C). This analysis suggests that 
our assay enriched for proteins that interact with RNA in both uninfected and infected 
primary fibroblasts.
To gain a sense of whether infection changes the abundance of host proteins associated with 
mRNA, we compared total spectral counts for individual host proteins detected in the mock 
and HCMV infected samples. Our data suggested that infection might increase the 
association of several host proteins with mRNA. Two such host proteins, the RNA helicases 
DDX3X and DHX9 were selected for further analysis. Both proteins co-purified with 
oligo(dT) from uninfected cell lysates (Fig. 2A), consistent with previous results (52, 105). 
Micrococcal nuclease treatment inhibited binding of both proteins, demonstrating that the 
association was dependent on the presence of RNA and not the result of non-specific 
interactions with the cellulose beads (Fig. 2B). Infection increased the amount of each 
protein associated with mRNA, stimulating the binding of DHX9 to a greater extent than 
DDX3X (Fig. 2A). The increased association was likely due to the increased levels of 
DDX3X and DHX9 observed in HCMV-infected cells. We conclude that HCMV infection 
changes the abundance of two host RNA-binding proteins associated with mRNA during 
infection. While our data suggests similar changes may occur for additional host proteins, 
we caution that further studies are needed to confirm these changes for individual host 
proteins.
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HCMV pTRS1 and pUS22 associate with mRNA in HCMV infected cells
In addition to cellular proteins, oligo(dT) eluates from infected cells also contained viral 
proteins (Table S1). Two of the viral proteins, pTRS1 and pUS22, contain a US22 
superfamily domain, yet the proteins differ in their subcellular localization. pTRS1 is found 
predominantly in the cytoplasm throughout infection (Fig. 3A and (81)). Conversely, pUS22 
is primarily found in the nucleus (Fig. 3A, bottom (71)). pTRS1 was previously shown to 
bind mRNA in vitro (33), although the association of pTRS1 with mRNA during HCMV 
infection has not been reported. Both pTRS1 and pUS22 co-purified with oligo(dT) 
throughout a time course of HCMV infection (Fig. 3B). Micrococcal nuclease treatment 
diminished the amount of pTRS1 and pUS22 that co-purified with oligo(dT), demonstrating 
an RNA-dependent interaction with the beads (Fig 3C,D). The host poly (A) binding protein 
(PABP1), a well-characterized cellular RNA-binding protein (28), was used as a control in 
these experiments (Fig 3C). These data are the first report of pTRS1 binding to mRNA in 
the context of HCMV infection and also validate the ability of oligo(dT) coupled proteomics 
to capture and identify both nuclear and cytoplasmic HCMV proteins associated with 
mRNA. In addition, these data identify the first molecular activity for HCMV pUS22 as an 
RNA-associated protein.
HCMV pp71 is an RNA-associated protein
We also identified the HCMV pp71 protein in our proteomics analysis. While several 
functions have been ascribed to pp71 (13, 45, 46, 98) it has not previously been shown to 
associate with mRNA. To examine the association of pp71 with mRNA in more detail, we 
measured the association of pp71 with oligo(dT) cellulose throughout a time course of 
HCMV infection (Fig. 4C). pp71 co-purified with oligo(dT) cellulose as early as 24 hours 
after infection, and the amount of pp71 associated with the resin increased as infection 
progressed. The increase in pp71 binding over time was proportional to the increase in pp71 
expression. Micrococcal nuclease treatment reduced pp71 co-purification with oligo(dT) 
beads, indicating that co-purification with the beads is dependent on the presence of mRNA 
(Fig. 4B)
In order to determine if other viral factors are required for the association of pp71 with 
mRNA, we determined if pp71 could associate with mRNA outside of the context of 
infection. Cells were transfected with a vector expressing pp71, and the ability of pp71 to 
co-purify with oligo(dT) cellulose was determined by Western blot (Fig. 4D). As during 
infection, pp71 co-purified with oligo(dT) and micrococcal nuclease treatment inhibited the 
interaction. These data confirm our proteomics data and show that pp71 associates with 
mRNA in HCMV-infected cells. In addition the interaction between pp71 and mRNA is not 
mediated by additional viral factors.
pp71 associates with mRNA in the nucleus and cytoplasm
In newly infected cells, tegument-derived pp71 localizes in the nucleus. In contrast, nascent 
pp71 localizes primarily to the cytoplasm where it contributes to HCMV replication through 
an unknown mechanism (38). In order to visualize the location of pp71 at various times 
during infection we performed indirect immunofluorescence for pp71 at various times after 
infection with HCMV (Fig. 4A). As previously reported pp71 was only found in the nucleus 
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until 48 hours post infection, when some pp71 began to appear in the cytoplasm. By 96 
hours after infection pp71 was primarily found in the cytoplasm of infected cells. To 
determine if pp71 preferentially associates with mRNA in the nucleus or cytosol, we 
measured the association of pp71 with oligo(dT) in nuclear and cytosolic extracts from 
infected cells. We analyzed samples at 72 hours after infection for this experiment, a time 
when pp71 is present in both cellular compartments. Both nuclear and cytosolic pp71 co-
purified with the oligo(dT) cellulose and binding in both locations was decreased by 
micrococcal nuclease treatment (Fig. 4E). We conclude that pp71 can bind mRNA in both 
the nuclear and cytoplasmic compartments.
pp71 associates with host and viral mRNAs
Our finding that pp71 co-purified with oligo(dT) cellulose in an RNA-dependent manner 
suggested that pp71 might associate with viral transcripts during infection. We therefore 
measured the association of pp71 with specific host and viral mRNAs in HCMV-infected 
cells. pp71-specific immune complexes were isolated from infected cell lysates and the 
associated RNAs were extracted and analyzed by quantitative reverse-transcriptase real time 
PCR (qRT-PCR). As a control we measured the abundance of specific mRNAs in immune 
complexes specific for the HCMV IE1 protein, which is not known to associate with 
mRNA. pp71-specific immune complexes were enriched for the HCMV IE1, UL44 and 
UL99 mRNAs compared to the IE1 control (Fig. 5A). The host GAPDH mRNA was also 
enriched in pp71 immune complexes, demonstrating that pp71 associates with a host mRNA 
during infection. Ribosomal RNAs were not found in pp71 immune complexes, and no 
signal was observed when the reverse transcription step was omitted (data not shown). We 
conclude that pp71 associates with mRNAs in HCMV infected cells. These results also 
suggest that pp71 may not discriminate between host and viral transcripts.
A portion of pp71 associates with polysomes during infection
We next determined if pp71 associates with actively translating mRNA in HCMV infected 
cells. mRNAs undergoing high levels of translation are bound by multiple ribosomes, or 
polysomes, which migrate into the dense fractions of linear sucrose gradients. We reasoned 
that if pp71 were associated with actively translating mRNAs then pp71 should co-migrate 
with polysomes in a sucrose gradient. Cytoplasmic lysates from HCMV-infected cells were 
resolved through 10–50% linear sucrose gradients to separate ribosomal subunits, 
monosomes, and polysomes. The sucrose gradients were fractionated, and the distribution of 
pp71 throughout the gradient was determined by Western blot (Fig. 6A). The majority of 
pp71 localized to lighter fractions of the gradient, which contains RNP complexes and free 
mRNAs (68). However, a portion of the pp71 was detectable throughout the gradient, 
including the heavier fractions containing polysomes.
In order to confirm that the migration of pp71 in the gradient reflected an association with 
polysomes, we determined the effect of disrupting ribosomes on the abundance of pp71 in 
the polysome-containing fractions. High concentrations of EDTA disrupt ribosomes and 
thus deplete polysomes from the denser fractions of the gradient (11). EDTA treatment 
reduced the abundance of ribosomes in the more dense gradient fractions as demonstrated by 
the reduced abundance of the ribosomal protein S6 (rpS6) (Fig. 6B). Consistent with 
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previous results, the HCMV UL69 protein (pUL69) was also present in polysome-
containing fractions and its abundance in these fractions was also diminished by EDTA 
treatment (Fig. 6B) (2). EDTA treatment also reduced the abundance of pp71 in the 
polysome-containing gradient fractions. As cytosolic lysates were used in the polysome 
analysis, these data support our above conclusion that pp71 associates with mRNA in the 
cytosol. We conclude that a portion of pp71 associates with polysomes in infected cells and 
therefore likely interacts with translation competent mRNAs.
The pp71-binding partner pUL35A also associates with mRNA, however, its interaction 
with pp71 is RNA-independent
Another HCMV tegument protein, pUL35, has been shown to interact with pp71 in the 
nucleus of infected cells (84). Recently, however, the smaller isoform of pUL35, pUL35A, 
was also found to co-localize with pp71 in the cytoplasm. Proteomic analysis of pUL35A 
found that pUL35A associates with several RNA binding proteins during HCMV infection 
(83), suggesting that pUL35A might also associate with RNA. To determine if pUL35A 
associates with mRNA, we measured the ability of pUL35A to co-purify with oligo(dT) 
cellulose in transfected cells. pUL35A co-purified with oligo(dT) cellulose in an RNA-
dependent manner, as micrococcal nuclease treatment diminished the interaction (Fig 7A). 
pUL35A also co-purified with oligo(dT) in the presence of pp71, however the amount of 
pUL35A co-purifying with oligo(dT) was slightly reduced when pp71 was present (Fig. 
7A). Two isoforms of pUL35A were consistently detected in cells transfected with both 
pp71 and pUL35A: the larger isoform was only observed in the presence of pp71. While the 
nature of the larger isoform is currently unknown, this result suggests that pp71 might 
induce a post-translational modification of pUL35A that is not necessary for pUL35A to 
associate with RNA. These results show that pUL35A can associate with mRNA outside of 
infection. In addition these results demonstrate that our proteomics dataset is not complete, 
and that HCMV encodes additional RNA-associated proteins not identified by our approach.
Our finding that both pp71 and pUL35A associate with mRNA suggested that perhaps the 
interaction of pUL35A and pp71 is bridged by an RNA intermediate. In order to determine 
if pp71 binding to pUL35A is mRNA dependent, we determined if micrococcal nuclease 
digestion prevented the interaction in transfected cells. pp71 co-precipitated with pUL35A 
and the interaction was not inhibited by micrococcal nuclease treatment (Fig. 7B). We 
conclude that while both pp71 and pUL35A interact with mRNA, the pp71:pUL35A 
interaction does not require an RNA intermediate.
Protein synthesis is increased in cells expressing pp71 and pUL35A
Since pp71 and pUL35A both associate with mRNA we investigated the impact of these 
proteins on the overall rate of protein synthesis. When expressed alone, pp71 and pUL35A 
increased total protein synthesis (Fig. 8A, B) as compared to control cells expressing GFP. 
Co-expressing pp71 and pUL35A together increased protein synthesis to a greater extent 
than either protein alone. However, pp71 and pUL35A did not confer stress resistant protein 
synthesis as observed during infection (18, 57, 72), as inhibiting the host translation 
initiation complex eIF4F with an mTOR inhibitor limited protein synthesis in pp71 and 
pUL35A expressing cells (data not shown). While these data do not exclude the possibility 
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that pp71 and UL35A may globally alter transcription or RNA stability, the increase in 
protein synthesis in the presence of pp71 and pUL35A together with our finding that pp71 
associates with polysomes and mRNAs during infection suggest that these proteins act in 
concert to increase translation.
Discussion
We have used a rapid, unbiased proteomics method to identify RNA-associated proteins 
during viral infection. Our approach identified known host RNA-associated proteins and for 
two such proteins, DDX3X and DHX9, identified changes in their abundance during 
infection. Importantly, our approach also identified both known and previously undescribed 
HCMV RNA-associated proteins. Using this approach we identified and confirmed the 
novel association of two HCMV proteins, pUS22 and pp71, with mRNA in infected cells. 
We also demonstrate for the first time that pTRS1, a known HCMV RNA-binding protein 
(33), associates with mRNA during infection. Together these results demonstrate that this 
approach captures both nuclear and cytosolic HCMV RNA-associated proteins. We also 
demonstrate a new activity for the HCMV pp71 protein as an RNA-associated protein that 
associates with actively translating host and viral mRNAs during infection. These results 
demonstrate that oligo(dT) affinity chromatography coupled with mass spectrometry is an 
efficient means for identifying herpesvirus proteins associated with RNA during viral 
infection.
Past studies using oligo(dT) capture coupled with proteomics have identified many factors 
involved in mRNA expression and metabolism (4, 14). In this study we used a similar 
approach to identify previously undetected interactions of HCMV proteins with mRNA 
during lytic infection. We previously used a similar screen to identify host proteins that 
specifically interact with poliovirus genomic RNA during infection (56). In contrast, HCMV 
infected cells express hundreds of viral transcripts as well as thousands of host RNAs. Thus 
in this study, oligo(dT) affinity purification captures host and viral proteins associated with 
either host or HCMV transcripts. The viral proteins identified by this approach could 
therefore be involved in post-transcriptional regulation of viral transcripts, or alternatively 
the expression and metabolism of host mRNAs.
Several aspects of our approach make it easily adaptable for use in other viral systems. Our 
approach relies on commercially available reagents, and comparable mass spectrometers are 
available in many academic proteomics core facilities. The relatively small sample size 
required suggests this approach could be adapted to identify viral RNA-binding proteins 
expressed during lytic or latent infection. While we could confirm changes in the abundance 
of host proteins associated with mRNA, more quantitative mass spectrometry techniques 
(e.g. SILAC, iTRaQ, reviewed in (73)) could be incorporated to precisely measure changes 
in the abundance of host or viral RNA-associated proteins throughout a time course of 
infection. Applying oligo(dT) coupled proteomics should prove useful in many viral culture 
systems for quantitatively identifying proteins, either host or viral, associated with RNA.
In its current form our approach was sufficient to identify new activities for pp71 and pUS22 
as HCMV RNA-associated proteins. In addition we could confirm that a known HCMV 
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RNA-binding protein, HCMV pTRS1, associates with mRNA during HCMV infection. 
However, our results also show that our approach is not comprehensive, as we did not detect 
the known viral RNA-binding pUL69 and the pUL35A protein co-purified with oligo(dT) 
cellulose in transfected cells but was not detected in our proteomics screen. In the case of 
pUL69 this could reflect a relatively low affinity of pUL69 for RNA, as its RNA-binding 
ability is not required for its function as a nuclear export factor for HCMV transcripts (63). 
Perhaps the use of more sensitive instrumentation would provide greater depth. 
Alternatively, the stringent binding and wash conditions of our approach were designed to 
limit false positives, perhaps giving rise to false negatives. Nonetheless, our current 
approach was sufficiently sensitive to identify known and unknown interactions that we 
could subsequently confirm using traditional molecular biology techniques.
Our results also identify new RNA-associated roles for previously characterized HCMV 
proteins. The HCMV pUS22 protein is an abundant nuclear protein that is also found in the 
supernatant of infected cells (71). While pUS22 is the namesake member of a family of 
related betaherpesvirus proteins (17), no function has been described for HCMV pUS22. 
Thus our finding that pUS22 associates with mRNA is the first functional annotation for 
pUS22. We hypothesize that pUS22 may play a role in RNA splicing or export based on its 
presence at high levels in the nucleus of infected cells, however additional experiments are 
needed to test this hypothesis. Of note is the fact that HCMV pTRS1 is a member of the 
US22 family of proteins and also associates with mRNA (33). Perhaps US22 family 
members share a common function in the post-transcriptional control of viral gene 
expression. This idea is consistent with previous studies demonstrating a role for pTRS1 and 
its MCMV homologs as antagonists of the antiviral kinase PKR (34). It is also possible that 
some of the RNA-associated proteins we identified may interact with polyadenylated RNAs 
that are not mRNAs, as some non-coding RNAs such as lncRNAs can also be 
polyadenylated (reviewed in (106)).
We also identified a new function for HCMV pp71 as an mRNA associated protein. We 
found that pp71 interacts with mRNA in infected and transfected cells, associates with 
polysomes during infection and stimulates protein synthesis both alone and in conjunction 
with its binding partner pUL35A. How the association of pp71 and pUL35A with mRNA 
might affect viral gene expression or replication is currently unclear. pp71 binds to the host 
BclAF1 protein (55), which is a component of an RNP complex that regulates mRNA 
processing and transport (70). Perhaps pp71 modulates BclAF1 activity, thereby effecting 
host or viral gene expression at the post-transcriptional level. Another possibility is that 
pp71 and pUL35A together inhibit cellular stress responses that would otherwise limit viral 
protein synthesis. pUL35A associates with the host G3BP1 protein (83), which limits 
translation during viral infections by sequestering mRNAs in cytoplasmic puncta termed 
stress granules (97) (69). Perhaps pUL35A and pp71 limit stress granule formation or 
sequestration of viral mRNAs into stress granules, thereby promoting viral protein synthesis. 
However it is also possible that pp71 and UL35A increase protein synthesis through a global 
effect on transcription or RNA stability. In any case, our finding that pp71 binds to mRNA 
provides direction for future studies to define a role for pp71 in the post-transcriptional 
control of gene expression during HCMV infection.
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In summary, we show that oligo(dT) affinity capture coupled with proteomics is a useful 
approach to identify proteins that associate with RNA, either host or viral, during infection. 
Given recent insights into the surprising complexity of the HCMV transcriptome, our 
approach provides a straightforward and practical means of identifying viral proteins that 
may manipulate mRNA processing, export, stability or translation. Our results identify new 
activities for viral proteins and also provide new directions for defining the underlying 
processes HCMV uses to regulate viral gene expression.
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• We used an unbiased proteomics approach to identify RNA-associated proteins 
during HCMV infection.
• We confirmed changes in abundance and activity for two host RNA-binding 
proteins, DHX9 and DDX3.
• We identified and confirmed three HCMV-RNA binding proteins during 
infection, pUS22, pTRS1 and pp71.
• pp71 associated with host and viral mRNAs and associated with polysomes in 
infected cells, and increased protein synthesis.
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Figure 1. Oligo(dT) capture combined with mass spectrometry identifies HCMV proteins 
associated with mRNA
(A) Flow chart of the method used to identify HCMV mRNA associated proteins. (B) 
Proteins isolated using the method in A were separated by SDS-PAGE and visualized using 
GelCode Blue staining. Left panel; the effect of micrococcal nuclease treatment on the 
complement and intensity of oligo(dT)-associated proteins. Right Panel; Gel showing 
oligo(dT)-associated proteins isolated from uninfected or HCMV-infected fibroblasts. 
Arrows denote bands specific to infected cells. (C) Gene ontogeny analysis shows that 
Lenarcic et al. Page 20













cellular proteins detected by LC-MS/MS after oligo (dT) capture are significantly enriched 
for RNA-associated functions.
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Figure 2. HCMV infection changes the activity of host RNA-binding proteins
(A) HFFs were infected with HCMV AD169 at a multiplicity of three and harvested at the 
indicated times following infection. The abundance of the host DDX3X and DHX9 proteins 
in oligo(dT) precipitates (bound) or total cell lysate (input) was measured by Western blot. 
(B) Seventy two hours after infection oligo(dT) precipitates were isolated from infected cell 
lysates and analyzed by Western blot. Where indicated the samples were treated with 
micrococcal nuclease (+MN) to confirm that the interaction is RNA dependent. The results 
in A and B are representative of at least two independent experiments.
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Figure 3. Confirmation that HCMV pUS22 and pTRS1 associate with mRNA during HCMV 
infection
(A) HFFs were infected with HCMV strains expressing GFP-tagged TRS1 (TRS1-GFP) or 
US22 (US22-GFP). Seventy-two hours after infection protein localization was visualized by 
confocal microscopy. (B) Oligo(dT) precipitates from cells infected with a US22GFP virus 
throughout a time course of infection were analyzed by Western blot with GFP (US22GFP) 
or TRS1-specific antibodies. (C) Cells were infected with the US22GFP virus and oligo(dT) 
associated proteins were analyzed by Western blot using GFP and PABP specific antibodies 
at seventy two hours after infection. Where indicated the lysates were treated with 
micrococcal nuclease (+MN) prior to incubation with oligo(dT) beads. (D) Cells were 
infected with the TRS1GFP virus for seventy two hours and the presence of pTRS1 in the 
oligo(dT) precipitate was measured by Western blot (C). All results are representative of 
three independent experiments.
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Figure 4. HCMV pp71 associates with mRNA during HCMV infection
(A) The location of GFP or pp71 was determined throughout a time course of infection by 
confocal microscopy. (B) Oligo(dT) precipitates from HCMV infected cells (72 hpi) were 
analyzed by Western blot. Where indicated, the lysates were incubated with micrococcal 
nuclease (+MN) prior to oligo(dT) capture. (C) Oligo(dT) precipitates were isolated from 
HCMV infected cell lysates at the indicated times after infection and analyzed by Western 
blot using a pp71-specfic antibody. (D) Oligo(dT) precipitates were isolated from HeLa cells 
transfected with a pp71 expression vector and analyzed by Western blot. (E) Seventy two 
hours after HCMV infection oligo(dT) precipitates were isolated from nuclear or 
cytoplasmic fractions and analyzed by Western blot. All experiments are representative of at 
least three independent experiments.
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Figure 5. pp71 associates with host and viral mRNAs during infection
(A) Lysates from infected HFFs (72hpi) were immunoprecipitated with antibodies specific 
for pp71 or IE1. The abundance of IE1, UL44, UL99 or GAPDH transcript in the immune 
complexes was quantified by qRT-PCR. Error bars indicate the standard error of the mean 
(n=3). (B) Western blots were performed on immunoprecipitated fractions from A with 
antibodies specific to pp71.
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Figure 6. pp71 associates with polysomes during HCMV infection
(A) Lysate from infected HFFs (72 hpi) was resolved through a 10–50% linear sucrose 
gradient and the gradient was fractionated. Aliquots from each fraction were either TCA 
precipitated and analyzed by Western blot (top) or total RNA was extracted and separated 
on an agarose gel to visualize ribosomal RNA (bottom). The black bar denotes the location 
of polysome-containing fractions. (B) Seventy two hours after infection cells were lysed in 
buffer with or without added EDTA. The lysates were separated by sucrose gradient 
centrifugation as in A and aliquots of the polysomes-containing fractions were pooled, 
precipitated and analyzed by Western blots with antibodies specific to pp71, UL69 or rpS6. 
The data are representative of at least two independent experiments.
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Figure 7. pp71 and UL35A associate with mRNA, but do not require RNA for their interaction
(A) Oligo(dT) precipitates were isolated from HeLa cells transfected with combinations of 
empty vector, pp71-HA, and pUL35A-GFP. Where indicated the lysate was treated with 
micrococcal nuclease (+MN) prior to capture. The bound proteins were analyzed by Western 
blot. (B) HeLa cells were transfected with a pp71-HA expression plasmid with or without a 
vector expressing pUL35A as a carboxyl-terminal GFP fusion protein (pUL35A-GFP). 
GFP-specific immune complexes were isolated and analyzed by Western blot using the 
indicated antibodies. Where indicated, lysates were treated with micrococcal nuclease 
(+MN) prior to immunoprecipitation. The data are representative of at least three 
independent experiments.
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Figure 8. pp71 and UL35A expression increases total protein synthesis
(A) HeLa cells were transfected with plasmids expressing pEGFP, pp71, pUL35A or both 
pp71 and pUL35A. Newly synthesized proteins were labeled metabolically and quantified 
by liquid scintillation. The results were normalized to the amount of total protein in each 
sample and are expressed as percent of counts detected in the GFP control. Error bars 
indicate the standard error of the mean (n=6). * = p < 0.05, ** = p < 0.01, *** = p < 0.001 
(B) Radiolabeled proteins from A were separated on SDS-PAGE gels and visualized by 
autoradiography.
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Table 1
Host RNA-associated proteins identified by oligo(dT) proteomics
The uniprot accession numbers (http://www.uniprot.org/) and gene names for the top thirty identified host 
proteins. The third column notes previous studies demonstrating an RNA-associated activity for the specified 
protein.
Uniprot # Gene Description RNA associated activity
P52272 Heterogeneous nuclear ribonucleoprotein M 21, 25, 44, 65
P11940 Polyadenylate-binding protein 1 19, 20, 30, 65, 103
P22626 Heterogeneous nuclear ribonucleoproteins A2/B1 6, 43, 79, 104
P23246 Splicing factor, proline- and glutamine-rich 29, 77, 88
P27694 Replication protein A 70 kDa DNA-binding subunit
Q00839 Heterogeneous nuclear ribonucleoprotein U 23, 50, 108
P07910 Heterogeneous nuclear ribonucleoproteins C1/C2 6, 9, 39, 79, 104
P08670 Vimentin
Q13310 Poly(A) binding protein 4 43
P14866 Heterogeneous nuclear ribonucleoprotein L 32, 40, 41, 64, 80, 90
P16989 Y-box-binding protein 3
O43390 heterogeneous nuclear ribonucleoprotein R 37, 43
O15523 ATP-dependent RNA helicase DDX3Y 3, 27, 47, 51, 70, 89, 93, 105
O00571 ATP-dependent RNA helicase DDX3X 3, 27, 47, 51, 70, 89, 93, 105
Q04837 Single-stranded DNA-binding protein, mitochondrial
Q96G97 Seipin
Q15233 Non-POU domain-containing octamer-binding protein 5, 88, 109
Q96AE4 Far upstream element-binding protein 1 42, 58
O14979 Heterogeneous nuclear ribonucleoprotein D-like 48, 75
P51991 Heterogeneous nuclear ribonucleoprotein A3 67
P67809 Nuclease sensitive element binding protein-1 36, 43, 66, 91, 94, 101
O75534 Cold shock domain-containing protein E1 7, 15, 31
Q9Y3F4 Serine-threonine kinase receptor-associated protein 16, 100
P09651 Heterogeneous nuclear ribonucleoprotein A1 6, 43, 79, 104
Q9Y2W1 Thyroid hormone receptor-associated protein 3 53, 99
Q08211 ATP-dependent RNA helicase A (DHX9) 24, 35, 52, 59, 78, 102
Q15717 ELAV-like protein 1 8, 102
P11142 Heat shock cognate 71 kDa protein 43
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